L Vamvakas Selected Research

Type I DNA Topoisomerases (Topoisomerase I)

1/2001

A phase I clinical trial of topotecan given every 2 weeks in patients with refractory solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Vamvakas Research Topics

Disease

8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2017 - 12/2001
7	Colorectal Neoplasms (Colorectal Cancer) 12/2012 - 02/2002
7	Neoplasms (Cancer) 11/2011 - 01/2001
6	Neutropenia 03/2017 - 01/2001
6	Breast Neoplasms (Breast Cancer) 01/2015 - 09/2001
3	Diarrhea 03/2017 - 01/2007
3	Disease Progression 01/2016 - 01/2007
3	Febrile Neutropenia 01/2012 - 01/2006
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2010 - 01/2001
2	Nausea 01/2006 - 01/2006
2	Vomiting 01/2006 - 01/2006
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2015
1	Adenocarcinoma 04/2015
1	Neoplasm Metastasis (Metastasis) 12/2012
1	Proteinuria 08/2010
1	Esophagitis 06/2010
1	Adenocarcinoma of Lung 01/2009
1	Circulating Neoplastic Cells 05/2007
1	Exanthema (Rash) 01/2007
1	Carcinoma (Carcinomatosis) 11/2006
1	Prostatic Neoplasms (Prostate Cancer) 01/2005
1	Fatigue 01/2001
1	Ovarian Neoplasms (Ovarian Cancer) 01/2001

Drug/Important Bio-Agent (IBA)

10	Irinotecan (Camptosar)FDA LinkGeneric 03/2017 - 12/2001
8	Cisplatin (Platino)FDA LinkGeneric 03/2017 - 12/2001
8	Gemcitabine FDA Link 01/2016 - 01/2006
7	Docetaxel (Taxotere)FDA Link 04/2015 - 01/2005
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2012 - 01/2006
6	Fluorouracil (Carac)FDA LinkGeneric 12/2012 - 09/2001
6	Leucovorin (Folinic Acid)FDA Link 12/2012 - 09/2001
5	Bevacizumab (Avastin)FDA Link 04/2015 - 08/2010
3	Vinorelbine (Navelbine)FDA LinkGeneric 04/2015 - 01/2006
3	Capecitabine (Xeloda)FDA Link 01/2012 - 02/2007
2	Pemetrexed (MTA)FDA Link 03/2017 - 01/2006
2	Cetuximab (Erbitux)FDA Link 12/2012 - 02/2007
2	liposomal doxorubicin (Doxil)FDA Link 01/2006 - 01/2005
1	PlatinumIBA 03/2017
1	Bortezomib (Velcade)FDA Link 01/2016
1	thiamine triphosphorate (TTP)IBA 11/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2010
1	Etoposide (VP 16)FDA LinkGeneric 06/2010
1	Messenger RNA (mRNA)IBA 05/2007
1	ErbB Receptors (EGF Receptor)IBA 02/2007
1	Monoclonal AntibodiesIBA 02/2007
1	Immunoglobulin G (IgG)IBA 02/2007
1	Gefitinib (Iressa)FDA Link 01/2007
1	Aligeron (AS 2)IBA 01/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2006
1	1-dodecylpyridoxal (PLD)IBA 01/2006
1	Hormones (Hormone)IBA 01/2005
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2001
1	AnthracyclinesIBA 09/2001
1	Taxoids (Taxanes)IBA 09/2001
1	EnzymesIBA 01/2001
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2001
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2001

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 03/2017 - 09/2001
5	Therapeutics 01/2016 - 01/2001
3	Treatment Delay 01/2006 - 01/2006
2	Salvage Therapy 03/2017 - 01/2008
2	Adjuvant Chemotherapy 05/2007 - 08/2005
1	CP protocol 03/2017
1	capecitabine-irinotecan combination 01/2012
1	Radiotherapy 06/2010
1	Consolidation Chemotherapy 06/2010